NCT05376254Recruiting
3D Assessment of RV Function in Patients Undergoing LVAD Implantation
Three-Dimensional Assessment of Right Ventricular Function in Patients Undergoing Left Ventricular Assist Device Implantation
Source: ClinicalTrials.gov · Last updated 29 May 2026
Brief summary (registry, in English)
This goal of this study is to analyze images of the right ventricle taken via 3D transesophageal echocardiography (TEE) during left ventricular assist device (LVAD) implantation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 27 Jan 2022
- Start date
- 22 Mar 2022
- Primary completion date
- 19 Jan 2027
- Lead sponsor
- University of Alberta
- Diseases
- Heart failure
- NCT number
- NCT05376254
What you commit to
- Study type: Observational
- Planned participants: 200
- From 22 Mar 2022 to the primary completion date, 19 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients will be excluded if::
- hemodynamic data needed to calculate PAPi or comprehensive echocardiographic images are missing
- additional procedures affecting cardiac geometry and/or hemodynamic measurements, such as tricuspid, mitral, and/or aortic valve repair/replacement, were performed at the time of LVAD implantation
- sternal closure at the end of the procedure is not possible
- RV mechanical support was introduced concurrently with LVAD implantation
- inadequate image quality required to obtain a 3D protocol
- known contraindication to TEE
- unexpected inability to advance probe into the mid-esophagus
Who the study is looking for
- Patients will be eligible to be included in the study if they receive either a left-sided:
- HeartMate III (Thoratec, Pleasanton, CA)
- HeartWare HVAD (HeartWare, Oakville CA)
- Levitronix CentriMag (Levitronix LLC, Waltham, MA) LVAD.
Age in the registry: 16 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mazankowski Alberta Heart Institute Coordinator of this site? Confirm its status | Edmonton | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.